Sirdás sisdollui
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Giella
Buot deaivamat
Bajilčálus
Dahkki
Fáddá
Hildobáiki
ISBN/ISSN
Fáddágilkor
Viečča
Aiddostahtton
Bosentan alleviates the pro-fi...
Čujuhandieđut
Deakstadieđáhus
Sádde šleađgaboasttain
Čálit
Doalvvo čujuhusa
Doalvun: RefWorks
Doalvun: EndNoteWeb
Doalvun: EndNote
Bissovaš liŋka
Bosentan alleviates the pro-fibrotic phenotype of lung scleroderma fibroblasts: Implications for treatment of scleroderma.
Bibliográfalaš dieđut
Váldodahkkit:
Leask, A
,
Xu, S
,
Renzoni, E
,
Bou-Gharios, G
,
du Bois, R
,
Abraham, D
,
Black, C
Materiálatiipa:
Conference item
Almmustuhtton:
2005
Oažžasuvvandieđut
Govvádus
Geahča maid
Bargiidšearbma
Geahča maid
Bosentan attenuates the profibrotic gene expression profile of lung fibroblasts in scleroderma
Dahkki: Shiwen, X, et al.
Almmustuhtton: (2006)
Effects of bosentan on collagen type I synthesis on in vitro culture of scleroderma skin fibroblasts
Dahkki: S. Soldano, et al.
Almmustuhtton: (2011-01-01)
Successful Treatment with Bosentan of Lower Extremity Ulcers in a Scleroderma Patient
Dahkki: Alix Naert, et al.
Almmustuhtton: (2013-01-01)
CTGF overexpressing mice: a model for human scleroderma
Dahkki: Sonnylal, S, et al.
Almmustuhtton: (2006)
Bosentan Does Not Affect Renal Resistive Index in Scleroderma/Systemic Sclerosis Patients
Dahkki: Emma Di Poi, et al.
Almmustuhtton: (2023-11-01)